Skip to content
healthcare.dev

LYUMJEV Tempo Pen

NDC 0002-8235, Insulin lispro-aabc, injection, solution, from Eli Lilly and Company.

Product NDC
0002-8235
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761109
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8235 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN LISPRO100 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [Chemical/Ingredient]

Package NDCNDC-11Package
0002-8235-05000028235055 SYRINGE in 1 CARTON (0002-8235-05) / 3 mL in 1 SYRINGE (0002-8235-01)
0002-8235-99000028235991 SYRINGE in 1 CARTON (0002-8235-99) / 3 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c5a056e2-b568-4ca6-9ed8-79c010942d00
  • NADAC price for package 00002823505

    GET /v1/drugs/nadac/00002823505

Use it

Look up 0002-8235 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8235 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-8235. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.